Skip to main content
NCBI home page
Eye logoLink to Eye
. 2011 Oct 21;26(1):159–162. doi: 10.1038/eye.2011.257

Prevalence of ocular and oculodermal melanocytosis in Spanish population with uveal melanoma

E Carreño 1,*, M A Saornil 1,2, C Garcia-Alvarez 1,2, F Lopez-Lara 2,3, J M De Frutos-Baraja 2,3, A Almaraz 4
PMCID: PMC3259590  PMID: 22020174

Abstract

Purpose

The aim of this study was to determine the prevalence of ocular and oculodermal melanocytosis (ODM) among patients with uveal melanoma (UM) in a Spanish population.

Methods

Retrospective review of the medical records of patients with ODM among patients with UM.

Results

Ten (11 eyes) of 400 patients (2.7%) with UM associated had ODM. The mean age at diagnosis of UM among patients with ODM was 62 years. One patient had bilateral tumours. UM was diagnosed during a routine-examination in two cases. All tumours were medium (7/11) or large (4/11) in size, with a mean maximum base of 13 mm and height of 7 mm. No patient had extraocular extension or metastatic disease at diagnosis. Enucleation was done in five cases and I-125-brachytherapy in six. The mean follow-up was 43 months. One patient died because of metastasis 2 years after enucleation; one patient is currently on treatment of systemic metastasis 11 years after.

Conclusions

ODM is more frequent in spanish population with UM than in American population. Despite the risk of UM in ODM, it is often diagnosed late when a conservative treatment is not indicated.

Keywords: tumour, melanoma, ocular melanocytosis, oculodermal melanocytosis

Introduction

Ocular melanocytosis (OM), a congenital condition first described by the Japanese dermatologist Ota in 1939,1 is characterised by hyperpigmentation of the episclera and uvea2, 3 due to an increased number of fusiform dendritic melanocytes.4 When the disease involves the skin in the distribution of the ophthalmic branch of the trigeminal nerve, it is referred to as oculodermal melanocytosis (ODM) (nevus of Ota). OM/ODM are more common in Asian patients,5 but there is a clear association with the presence of uveal melanoma (UM) in Caucasians.6, 7, 8 Varying involvement of the orbit and meninges can occur.9

An association between UM and OM/ODM is supported strongly by previous findings such as the early onset of UM,10 the ipsilaterality of the OM/ODM with the UM, and sectorial OM/ODM progressing to UM in the affected sector11 as well as cases of bilateral and multifocal UM.10, 12 The association of ODM with malignant melanomas in the orbit or intracranially also was reported.13, 14, 15 Despite that, patients with OM/ODM sometimes do not have adequate follow-up.

The aim of this paper was to determine the relative incidence of OM/ODM in patients with UM in Spanish population.

Case reports

Patients from the Intraocular-Tumours-Unit of ‘Hospital Clínico Universitario de Valladolid' from 1992 to 2009 with concurrent UM and OM/ODM were included. This study was a case series. Diagnosis of UM was based on ophthalmoscopic appearance and ultrasonographic features. Pigmented lesions >1 mm in height or base >5 mm were included based on the criteria of the Collaborative Ocular Melanoma Study (COMS).16 The COMS size classification and the TNM classification system17 were used.

Diagnosis of ocular melanocytosis was based on biomicroscopic and ophthalmoscopic appearance, and oculodermal melanocytosis was diagnosed in the presence of dermal involvement.

Demographic information; onset; extent of melanocytosis, fundus-eye examination, B-mode-ultrasound with vector-A; measurement of tumour diameter, height, size, shape, and location were recorded. Ancillary tests were used to detect extraocular extension and identify systemic metastasis. Treatment included enucleation or I-125-brachytherapy. Pathology data were classified according to the modifications of Callender's-classification of UM at the Armed Forces Institute of Pathology.18 Follow-up examinations were conducted every 6 months during the first 5 years and yearly thereafter.

Data were codified in a database designed in Microsoft Access. A descriptive analysis was performed.

Eleven eyes (2.7%) (10 patients) of 401 (400 patients) in the UM database of the Intraocular Tumours Unit, with data recorded over the course of 17years, had OM/ODM. Demographic information and clinical features are recorded in Table 1. All patients presented a tumour ipsilateral to the eye with OM/ODM. All cases of OM/ODM showed a diffuse involvement, with affection of episclera, and uvea, plus skin involvement in the cases of ODM. No extraocular extension or metastatic disease was observed at the time of diagnosis of the UM in any patient.

Table 1. Clinical and tumour characteristics.

Case No Age (Years) Gender Eye OM/ ODM Symptoms At Onset Ultrasound
 Size Localization Shape Treatment Systemic Metastasis Follow-Up (months)
            Maximum base (mm) Height (mm)            
1 63 M OD OM No 13.00 4.45 Medium Choroid NODULAR BRACHYTHERAPY No 144
2 42 F OS OM Yes 16.10 2.93 Large Choroid INFILTRATIVE ENUCLEATION YES 15
3 31 M OS OM Yes 13.30 5.10 Medium Choroid NODULAR ENUCLEATION YES 90
4 79 M OD OM Yes 20.00 14.80 Large Choroid MUSHROOM ENUCLEATION No —
5 56 M OD OM Yes 9.79 4.58 Medium Choroid NODULAR BRACHYTHERAPY No —
6 84 F OS ODM Yes 18.00 13.00 Large Choroid MUSHROOM ENUCLEATION No 48
7 78 M OS OM No 11.43 7.63 Medium Choroid MUSHROOM BRACHYTHERAPY No 24
8 40 F OS ODM Yes 7.45 8.06 Medium Choroid MUSHROOM BRACHYTHERAPY No 9
9 76 M OD OM Yes 16.80 9.70 Large Ciliary Body MUSHROOM ENUCLEATION No —
10 75 M BE OM Yes 10.63 3.74 Medium Choroid NODULAR BRACHYTHERAPY No 13
            12.69 8.70 Medium Choroid MUSHROOM BRACHYTHERAPY No 2
Mean 62.40         13.31 7.52           43.13
SD 19.07         3.90 3.86           49.74
Open in a new tab

Abbreviations: SD, Standard deviation; M, Male; F, Female; OD, Right eye; OS, Left eye; BE, Both eyes; OM, Ocular Melanocytosis; ODM, Oculodermal melanocytosis.

Three patients underwent enucleation at ‘Hospital Clínico de Valladolid' one had the mixed-cell melanoma (case 2), one the spindle-cell melanoma (case 3), and one the epitheloid-cell melanoma (case 6).

In six cases treated with I-125-brachytherapy, the mean-dose to apex was 82.25 Gy. No intraocular tumour recurrence was observed during the follow-up.

One patient died because of metastasis 2 years after enucleation (case 2), and one patient is receiving systemic treatment for metastasis 11years after enucleation (case 3).

Discussion

OM/ODM affect only about 0.038% of the general Caucasian population,19 and, in this series, 2.7% of patients with UM had OM/ODM, indicating that OM/ODM is about 71 times more common in the UM population. Another series reported it to be about 35 times more common in patients with UM.8 Using Bayes' theorem and previous data, and a prevalence for UM of 7.5 × 10−5,20 the lifetime prevalence of UM in patients with OM/ODM was 5.32 × 10−3.

Unfortunately, there are no studies determining the prevalence of OM/ODM in a Spanish population, and the prevalence of 0.038% is from a general Caucasian population in the United States.19

Compared with other series, the current series presents a higher prevalence of OM/ODM in UM population. The prevalence reported ranged between 1.24 and 1.36%.6, 7, 8 The 2.7% prevalence rate in the current series is statistically higher than the 1.24%7 rate (P=0.03) and in the limits of statistical significance compared with the 1.36%6 rate (P=0.057). This disparity could be explained by differences between populations and environmental conditions. The decreasing north-to-south gradient of the incidences of UM in Europe was reported.21 The differences could result from the different eye colours,21 or exposure to solar radiation.22 It is then possible to assume that the risk factors for UM, such as OM/ODM, have different roles depending on the geographic area.

Although OM/ODM is a risk factor for UM, with a higher prevalence in our population, most patients have not had adequate follow-up; the main reason for the diagnosis was the development of visual symptoms. Most UM are diagnosed when they are medium to large in size, resulting in a high rate of enucleation. When the tumour is detected early, conservative treatment with brachytherapy is possible and effective and can preserve the eye and, in some cases, the visual acuity.

In conclusion, although OM/ODM are important risk-factors for UM, with a higher prevalence in our population, most patients do not have adequate follow-up. Yearly ocular examinations are recommended to preserve the eye and vision, and improve the prognosis.Inline graphic

Acknowledgments

The study was performed with informed consent, following all the guidelines for experimental investigations required by the Institutional Review Board or Ethics Committee to which all authors are affiliated.

The authors declare no conflict of interest.

Footnotes

Presented in part as an electronic poster at the 17th Congress of the European Society of Ophthalmology, June 2009, Amsterdam, The Netherlands.

References

  1. Ota M, Tamino H. A variety of nevus frequently encountered in Japan, nevus fusco-coeruleus ophthalmomaxilaris and its relation to pigmentary changes in the eye. Tokyo Med J. 1939;63:1242–1244. [Google Scholar]
  2. Fitzpatrick TB, Kitamura H, Kukita A, Zeller R. Ocular and dermal melanocytosis. AMA Arch Ophthalmol. 1956;56 (6:830–832. doi: 10.1001/archopht.1956.00930040838004. [DOI] [PubMed] [Google Scholar]
  3. Teekhasaenee C, Ritch R, Rutnin U, Leelawongs N. Ocular findings in oculodermal melanocytosis. Arch Ophthalmol. 1990;108 (8:1114–1120. doi: 10.1001/archopht.1990.01070100070037. [DOI] [PubMed] [Google Scholar]
  4. Yanoff M, Zimmerman LE. Histogenesis of malignant melanomas of the uvea. 3. The relationship of congenital ocular melanocytosis and neurofibromatosis in uveal melanomas. Arch Ophthalmol. 1967;77 (3:331–336. doi: 10.1001/archopht.1967.00980020333007. [DOI] [PubMed] [Google Scholar]
  5. Leung AK, Kao CP, Cho HY, Siu MP, Choi MC, Sauve RS. Scleral melanocytosis and oculodermal melanocytosis (nevus of Ota) in Chinese children. J Pediatr. 2000;137 (4:581–584. doi: 10.1067/mpd.2000.108208. [DOI] [PubMed] [Google Scholar]
  6. Gonder JR, Shields JA, Albert DM, Augsburger JJ, Lavin PT. Uveal malignant melanoma associated with ocular and oculodermal melanocytosis. Ophthalmology. 1982;89 (8:953–960. doi: 10.1016/s0161-6420(82)34694-1. [DOI] [PubMed] [Google Scholar]
  7. Velazquez N, Jones IS. Ocular and oculodermal melanocytosis associated with uveal melanoma. Ophthalmology. 1983;90 (12:1472–1476. doi: 10.1016/s0161-6420(83)34358-x. [DOI] [PubMed] [Google Scholar]
  8. Singh AD, De Potter P, Fijal BA, Shields CL, Shields JA, Elston RC. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology. 1998;105 (1:195–198. doi: 10.1016/s0161-6420(98)92205-9. [DOI] [PubMed] [Google Scholar]
  9. Gonder JR, Nichol J, Augsburger JJ, Shields JA. Ocular and oculodermal melanocytosis. Can J Ophthalmol. 1985;20 (5:176–178. [PubMed] [Google Scholar]
  10. Shields CL, Eagle RC, Ip MS, Marr BP, Shields JA. Two discrete uveal melanomas in a child with ocular melanocytosis. Retina. 2006;26 (6:684–687. doi: 10.1097/01.iae.0000236485.24808.f2. [DOI] [PubMed] [Google Scholar]
  11. Shields JA, Shields CL, Davidson R, Eagle RC., Jr Iris melanoma arising from sector congenital ocular melanocytosis in a child. Cornea. 2009;28 (10:1191–1193. doi: 10.1097/ICO.0b013e31819b3384. [DOI] [PubMed] [Google Scholar]
  12. Honavar SG, Shields CL, Singh AD, Deminci H, Rutledge BK, Shields JA, et al. Two discrete choroidal melanomas in an eye with ocular melanocytosis. Surv Ophthalmol. 2002;47 (1:36–41. doi: 10.1016/s0039-6257(01)00281-8. [DOI] [PubMed] [Google Scholar]
  13. Theunissen P, Spincemaille G, Pannebakker M, Lambers J. Meningeal melanoma associated with nevus of Ota: case report and review. Clin Neuropathol. 1993;12 (3:125–129. [PubMed] [Google Scholar]
  14. Kiratli H, Bilgic S, Satilmis M. Ocular melanocytosis associated with intracranial melanoma. Br J Ophthalmol. 1996;80 (11:1025. doi: 10.1136/bjo.80.11.1025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sagar HJ, Ilgren EB, Adams CB. Nevus of Ota associated with meningeal melanosis and intracranial melanoma. Case report. J Neurosurg. 1983;58 (2:280–283. doi: 10.3171/jns.1983.58.2.0280. [DOI] [PubMed] [Google Scholar]
  16. Singh AD. Clinical ophthalmic oncology. Elsevier Saunders: Edinburgh; 2007. [Google Scholar]
  17. Sobin LH, Gospodarowicz MK, Wittekind C.International Union against Cancer TNM classification of malignant tumours7th edn.Wiley-Blackwell: Chichester, West Sussex, UK; Hoboken, NJ; 2010 [Google Scholar]
  18. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol. 1983;96 (4:502–509. doi: 10.1016/s0002-9394(14)77914-0. [DOI] [PubMed] [Google Scholar]
  19. Gonder JR, Ezell PC, Shields JA, Augsburger JJ. Ocular melanocytosis. A study to determine the prevalence rate of ocular melanocytosis. Ophthalmology. 1982;89 (8:950–952. [PubMed] [Google Scholar]
  20. Shields JA, Shields CL.Intraocular tumors : an atlas and textbook2nd edn.Lippincott Williams & Wilkins: Philadelphia; 2008 [Google Scholar]
  21. Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, et al. Incidence of uveal melanoma in Europe. Ophthalmology. 2007;114 (12:2309–2315. doi: 10.1016/j.ophtha.2007.01.032. [DOI] [PubMed] [Google Scholar]
  22. Yu GP, Hu DN, McCormick SA. Latitude and incidence of ocular melanoma. Photochem Photobiol. 2006;82 (6:1621–1626. doi: 10.1562/2006-07-17-RA-970. [DOI] [PubMed] [Google Scholar]

Articles from Eye are provided here courtesy of Nature Publishing Group

RESOURCES